Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Accriva Diagnostics, Inc. — Predicate Candidate Screening
3 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K223352 | Tenderfoot | Accriva Diagnostics, Inc. | 2023-03-02 | 120 | 0 |
| K202101 | GEM Hemochron 100 System, GEM Hemochron 100 Activated Clotti | Accriva Diagnostics, Inc. | 2021-12-29 | 518 | 1 |
| K193041 | Hemochron Signature Elite | Accriva Diagnostics, Inc. | 2019-11-22 | 22 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda